The SEE-IT Trial: emergency medical services Streaming Enabled Evaluation In Trauma: a feasibility randomised controlled trial.
Journal Information
Journal Title: Scand J Trauma Resusc Emerg Med
Detailed journal information not available.
Publication Details
Subject Category: Emergency Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThe HRA granted favourable ethical opinion on 23 March 2022 (ref: 21/LO/0912, London—Camden & King’s Cross Research Ethics Committee), including NHS CAG approval (ref: 22/CAG/0003). Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."
"Funding This research was funded by the National Institute of Health Research (NIHR130811) Health and Social Care Delivery Research. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. The project is also supported by the Clinical Research Network. The trial sponsor and funding body contributed to the design of this study but will not have any role during its execution, analysis, interpretation if the data, writing of the report or the decision to submit the report for publication. The SEE-IT Trial Group includes all named authors as well as: Mark Cropley (School of Psychological Sciences, University of Surrey), Heather Gage (School of Biosciences, University of Surrey), Janet Holah (Patient Public Involvement and Engagement Lead), Jill Maben (School of Health Sciences, University of Surrey) and Carin Magnusson (School of Health Sciences, University of Surrey)."
"Trial registration . ISRCTN 11449333 (22 March 2022). https://www.isrctn.com/ISRCTN11449333"
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025